Chicago—Although dexamethasone may be a beneficial adjunct to surgery in terms of its antiemetic and anti-inflammatory effects, a team of researchers from Thomas Jefferson University Hospital has found that it may have a darker side, particularly in diabetic patients.
A pilot study concluded that dexamethasone administration was associated with significant postoperative hyperglycemia in these patients when undergoing functional endoscopic sinus surgery (FESS), which ultimately may lead to